A. Background: Aplastic anemia (AA) is a rare but potentially fatal disorder, with a reported higher incidence in developing countries in comparison to the West. There is a wide gap in awareness of and knowledge of the disease in Africa that leads to delayed diagnosis and referral, inappropriate treatment, and mismanagement of pediatric and elderly patients. Newton & Einstein Institute of Science and Technology (NEIST) has received funding from Pfizer to implement the ‘’Social Media for Aplastic Anemia Regional Training (SMAART)’’ project. The institute intends to recruit a Social Media Officer to support the SMAART project implementation.